Surrozen (SRZN) Operating Expenses (2020 - 2026)
Surrozen (SRZN) recorded quarterly Operating Expenses of $15.5 million in Q1 2026, up 17.38% quarter-over-quarter from $13.2 million in Q4 2025, and up 46.72% on a YoY basis from $10.5 million in Q1 2025.
Surrozen (SRZN) Operating Expenses (2020 - 2026) Analysis & Trends
Surrozen's Operating Expenses history runs 7 years deep, the most recent figure standing at $15.5 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 46.72% year-over-year to $15.5 million; the TTM figure through Mar 2026 stood at $50.5 million (up 34.29% YoY), while the FY2025 annual figure was $45.6 million, up 25.9% from the prior year.
- Operating Expenses was $15.5 million for Q1 2026 at Surrozen, up from $13.2 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $15.5 million in Q1 2026 to a low of $8.8 million in Q3 2024.
- Historically, Operating Expenses has averaged $11.8 million across 5 years, with a median of $11.2 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Operating Expenses tumbled 37.43% in 2024, then jumped 46.72% in 2026.
- A 5-year view of Operating Expenses shows it stood at $14.7 million in 2022, then tumbled by 33.71% to $9.7 million in 2023, then fell by 4.91% to $9.2 million in 2024, then surged by 42.39% to $13.2 million in 2025, then gained by 17.38% to $15.5 million in 2026.
- The last three Operating Expenses figures came in at $15.5 million (Q1 2026), $13.2 million (Q4 2025), and $11.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 15.76 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -67.40 Mn |
| 10 | Surrozen | 239,016.67 | -106.67 Mn | - | 15.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.46 Mn |
| Dec 31, 2025 | 13.17 Mn |
| Sep 30, 2025 | 11.87 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 10.53 Mn |
| Dec 31, 2024 | 9.25 Mn |
| Sep 30, 2024 | 8.77 Mn |
| Jun 30, 2024 | 9.05 Mn |
| Mar 31, 2024 | 9.13 Mn |
| Dec 31, 2023 | 9.72 Mn |
| Sep 30, 2023 | 11.19 Mn |
| Jun 30, 2023 | 10.28 Mn |
| Mar 31, 2023 | 14.59 Mn |
| Dec 31, 2022 | 14.67 Mn |
| Sep 30, 2022 | 13.61 Mn |
| Jun 30, 2022 | 14.07 Mn |
| Mar 31, 2022 | 14.49 Mn |
| Dec 31, 2021 | 15.00 Mn |
| Sep 30, 2021 | 13.71 Mn |
| Jun 30, 2021 | 12.66 Mn |